Clinical trials
Observational Urinary Incontinence trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Recruiting | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Izmir Democracy University | 3 |
| Pinar Yasar | 3 |
| Giresun University | 2 |
| Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 2 |
| Afyonkarahisar Health Sciences University | 1 |
| Akdeniz University | 1 |
| Ankara Medipol University | 1 |
| Ankara University | 1 |
| Antalya Training and Research Hospital | 1 |
| Artvin Coruh University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Incontinence | 37 |
| Multiple Sclerosis | 4 |
| Lower Urinary Tract Symptoms | 3 |
| Diabetes Mellitus | 2 |
| Fatigue | 2 |
| Malnutrition | 2 |
| Pelvic Floor Disorders | 2 |
| Pelvic Organ Prolapse | 2 |
| Prostatic Hyperplasia | 2 |
| Sexual Dysfunction, Physiological | 2 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.